A sequence-specific, nanoparticle-based biosensor platform for rapid and visual identification of serum hepatitis B virus pregenomic RNA in chronic hepatitis B patients
Microbiology Spectrum · 2026
DOI: 10.1128/spectrum.01918-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Yuanyuan Gu und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, People's Republic of China. Hauptthemen laut MEDLINE: Hepatitis B virus, Hepatitis B, Chronic, Biosensing Techniques, Nucleic Acid Amplification Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guizhou Provincial Key Technology R&D Program, Program of Scientific and Technological of Guiyang City.
Abstract (Originalsprache)
Chronic hepatitis B virus (HBV) infection is a major cause of liver-related morbidity and mortality worldwide. Serum HBV pregenomic RNA (pgRNA) is a surrogate marker for the transcriptional activity of covalently closed circular DNA. Here, we successfully designed a novel point-of-care (POC) diagnostic platform that allows specific, sensitive, rapid, and visual identification of HBV pgRNA. The platform integrates probe-based reverse transcription loop-mediated isothermal amplification (RT-LAMP) with either r estriction e ndonuclease-mediated real-time f luorescence (REF) or a gold nanoparticle-based lateral flow biosensor (AuNPs-LFB), termed HBV-RT-LAMP. A unique set of probe-based LAMP primers targeting HBV-pgRNA was successfully designed. The optimal conditions for HBV-RT-LAMP were determined to be 64°C and 30 min. AuNPs-LFB and a pocket fluorescence detector (REF assay) were used for readout of the products. Our assay detected the target gene at concentrations as low as 50 copies/mL of HBV RNA standard and did not produce cross-reactions with HBV DNA (treated with DNase I) or other pathogens. The entire detection process, including HBV RNA extraction (45 min), LAMP (30 min), and the interpretation of results (AuNPs-LFB, less than 2 min), could be performed within 80 min, with no need for expensive devices. Therefore, the HBV-RT-LAMP diagnostic system developed in this study can potentially serve as a useful POC diagnostic tool for the evaluation of chronic HBV infection status and antiviral drug efficacy. IMPORTANCE Chronic hepatitis B (CHB) is still a serious global concern that can result in severe liver-related diseases, including liver cirrhosis and hepatocellular carcinoma. Serum hepatitis B virus (HBV)-pregenomic RNA (pgRNA) has been proposed as a surrogate intrahepatic covalently closed circular DNA marker in CHB patients. Here, for the first time, a novel point-of-care diagnostic platform, termed HBV-reverse transcription loop-mediated isothermal amplification (RT-LAMP), which integrates probe-based RT-LAMP with either r estriction e ndonuclease-mediated real-time f luorescence (REF) detection or a gold nanoparticle-based lateral flow biosensor (AuNPs-LFB), was developed and applied for accurate, sensitive, specific, rapid, and visual identification of HBV-pgRNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, People's Republic of China.
- Medical Science Laboratory of Integrative Chinese and Western Medicine, The Second Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, People's Republic of China.
- Clinical Laboratory, Guizhou Provincial Center for Clinical Laboratory, Guiyang, Guizhou, People's Republic of China.
- Experimental Center, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, Guizhou, People's Republic of China.
- Experimental Research Center, Capital Center for Children's Health, Capital Medical University, Capital Institute of Pediatrics, Beijing, People's Republic of China.
Förderung
- National Natural Science Foundation of China
- Guizhou Provincial Key Technology R&D Program
- Program of Scientific and Technological of Guiyang City
- Laboratory of Microbiol and Infectious Disease prevention & Control in Guizhou Province
- Project for Public Health Talent Cultivation of China
- The local science foundation of Guizhou Province guided by the Central Committee of China
Zitieren
APA
Gu, Y., Zhao, Q., Tan, Y., Huang, J., Wang, Y., Li, S., & Chen, X. (2026). A sequence-specific, nanoparticle-based biosensor platform for rapid and visual identification of serum hepatitis B virus pregenomic RNA in chronic hepatitis B patients. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01918-25
Vancouver
Gu Y, Zhao Q, Tan Y, Huang J, Wang Y, Li S, et al. A sequence-specific, nanoparticle-based biosensor platform for rapid and visual identification of serum hepatitis B virus pregenomic RNA in chronic hepatitis B patients. Microbiology Spectrum. 2026. doi:10.1128/spectrum.01918-25
BibTeX
@article{Gu2026,
author = {Gu, Yuanyuan and Zhao, Qi and Tan, Yan and Huang, Junfei and Wang, Yi and Li, Shijun and Chen, Xu},
title = {A sequence-specific, nanoparticle-based biosensor platform for rapid and visual identification of serum hepatitis B virus pregenomic RNA in chronic hepatitis B patients},
journal = {Microbiology Spectrum},
year = {2026},
doi = {10.1128/spectrum.01918-25}
}
EUVIMED